4.7 Article

Effects of obesity therapies on sleep disorders

期刊

METABOLISM-CLINICAL AND EXPERIMENTAL
卷 84, 期 -, 页码 109-117

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.metabol.2018.01.022

关键词

Obesity interventions; Weight loss; Sleep; Obstructive sleep apnea syndrome

资金

  1. Eisai Inc [APD356-A001-403, 819111_10043752]
  2. Novo Nordisk Inc [ISS-001052, ISS-001033]

向作者/读者索取更多资源

Obesity is a significant risk factor for obstructive sleep apnea syndrome (OSAS), and has also been linked to reductions in sleep quality and quantity. Weight loss has been shown to be an effective treatment for improving OSAS; however, there is a high degree of variability in improvements of OSAS in response to weight loss. There are three modalities of obesity therapies: 1) lifestyle modification, which includes changes in dietary intake and physical activity, along with behavioral interventions; 2) pharmacologic agents; and 3) bariatric surgery. Individuals have a highly variable response to the various obesity interventions, and maintenance of weight loss can be especially challenging. These factors influence the effect of weight loss on sleep disorders. There is still a need for large, well-controlled studies examining short- and long-term efficacy of weight loss modalities and their impact on long-term treatment of OSAS and other sleep parameters, particularly in youth. Nonetheless, given our current knowledge, weight reduction should always be encouraged for people coping with obesity, OSAS, and/or sleep disruptions and resources identified to assist patients in choosing a weight loss approach that will benefit them the most. (C) 2018 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据